Genetic Technologies Quick Ratio 2010-2022 | GENE
Historical quick ratio values for Genetic Technologies (GENE) over the last 10 years.
| Genetic Technologies Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2022-06-30 |
$0.01B |
$0.00B |
3.76 |
| 2021-12-31 |
$0.01B |
$0.00B |
5.96 |
| 2021-06-30 |
$0.02B |
$0.00B |
15.77 |
| 2020-12-31 |
$0.01B |
$0.00B |
14.48 |
| 2020-06-30 |
$0.01B |
$0.00B |
10.81 |
| 2019-12-31 |
$0.00B |
$0.00B |
2.90 |
| 2019-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2018-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2018-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2017-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2017-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2016-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2016-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2015-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2015-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2014-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2014-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2013-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2013-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2012-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2012-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2011-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2011-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2010-12-31 |
$0.01B |
$0.00B |
4.21 |
| 2010-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2009-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2009-06-30 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.028B |
$0.005B |
|
Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.
|
